PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
03-Jun-2020 Santhera Announces Completion of ReveraGen’s Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
03-Jun-2020 AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie
03-Jun-2020 ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer The Institute of Cancer Research
03-Jun-2020 Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan Sanofi
03-Jun-2020 New First-in-Class Phase 3 TREMFYA®▼ (guselkumab) Data Demonstrate Improvement in Psoriatic Arthritis Joint and Skin Symptoms at Week 52 Janssen
03-Jun-2020 Envisagenics presents latest case study at Oligonucleotide Therapeutics and Delivery 2020 SMi Group Ltd
01-Jun-2020 Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline Daiichi Sankyo, Inc.
01-Jun-2020 Sanofi announces closing of Regeneron stock sale Sanofi
01-Jun-2020 Sanifit Enhances Leadership Team with New Executive Appointments Sanifit
01-Jun-2020 Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals Acacia Pharma Group plc
01-Jun-2020 ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting ERYTECH Pharma
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA Chi-Med
01-Jun-2020 Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC
01-Jun-2020 Immutep announces improving data from the phase II TACTI-002 study Immutep
01-Jun-2020 Immutep reports first results from INSIGHT-004 study Immutep Limited
01-Jun-2020 Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75 Calliditas Therapeutics
01-Jun-2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up Almac Group